Additionally, (and this has, to our knowledge, never been demonstrated for any ALL before), we also observed a significant increase in basal and TSLP-induced activity of both MEK1/2 and RAS in the HR-DS-ALL group, compared to the SR group. Here, MAP2K1 is linked to acute lymphoblastic leukemia.